Literature DB >> 3675695

Influence of ambroxol on amoxicillin levels in bronchoalveolar lavage fluid.

R Gené1, J J Poderoso, C Corazza, M B Lasala, J C Wiemeyer, M Fernández, R B Guerreiro.   

Abstract

Amoxicillin levels were measured in bronchoalveolar lavage (BAL) fluid samples obtained from patients who after randomization were treated in double-blind fashion either with amoxicillin 1000 mg p.o.t.i.d. or with amoxicillin 1000 mg + ambroxol 60 mg p.o.t.i.d. Antibiotic levels were higher in the group receiving ambroxol (0.32 +/- 0.02 micrograms/ml; n = 8) than in the other one (0.19 +/- 0.02 micrograms/ml; n = 6). This difference was statistically significant (p less than 0.001). Comparisons of protein concentrations in BAL fluid samples and of amoxicillin plasma levels did not show significant differences in the two groups. These results seem to prove that ambroxol is able to increase the antibiotics concentration in the lungs, although the mechanism of action is still unclear. In addition it could be shown that the BAL technique is suitable for exploring the lung concentration of antibiotics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675695

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery.

Authors:  Qiang Li; Gaiqi Yao; Xi Zhu
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 2.  Enhancement of lung levels of antibiotics by ambroxol and bromhexine.

Authors:  Vojo Deretic; Graham S Timmins
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-02-07       Impact factor: 4.481

3.  Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis.

Authors:  Feng Chen; Yuan-Xia Zhang; Cai-Qing Zhang
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

Review 4.  Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?

Authors:  Francesco Scaglione; Orlando Petrini
Journal:  Clin Med Insights Ear Nose Throat       Date:  2019-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.